Buy Zymeworks Stock | ZYME Stock Price & Latest News | Public
ZYME

Zymeworks

$0.00 (0.00%)Today

    About ZYME

    Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by A...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.55
    -1.11
    -1.66
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.93

    Actual EPS
    Q3 2020

    Stats

    Market Cap$2,06B
    Volume26,11k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$52.75
    1 Year Low$20.33
    Open$43.60
    High$45.39
    Low$43.49

    Buy any stock with any amount of money.

    Download the App
    Download the app